Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

China · Delayed Price · Currency is CNY

15.95

+0.05 (0.31%)

Apr 8, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Anti-infection	493.92M	282.34M	162.25M	-	-
Anti-infection Growth	74.94%	74.01%	-	-	-
Anti-Tumor	631.18M	616.95M	651.41M	799.71M	829.10M
Anti-Tumor Growth	2.31%	-5.29%	-18.54%	-3.55%	-18.65%
Other Category	22.20M	26.25M	43.55M	335.70M	323.97M
Other Category Growth	-15.43%	-39.73%	-87.03%	3.62%	177.12%
Chronic Diseases	323.39M	205.14M	145.74M	-	-
Chronic Diseases Growth	57.65%	40.75%	-	-	-
Digestive	269.90M	299.01M	856.01M	1.91B	2.57B
Digestive Growth	-9.74%	-65.07%	-55.09%	-25.73%	-23.76%
Unallocated Other Operations	37.05M	13.77M	13.61M	65.22M	63.37M
Unallocated Other Operations Growth	169.04%	1.19%	-79.13%	2.91%	288.15%
Total	1.78B	1.44B	1.87B	3.11B	3.78B
Total Growth	23.15%	-22.92%	-39.72%	-17.87%	-16.29%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	1.78B	1.44B	1.87B	3.11B	3.78B
China Growth	23.15%	-22.92%	-39.72%	-17.87%	-16.29%
Total	1.78B	1.44B	1.87B	3.11B	3.78B
Total Growth	23.15%	-22.92%	-39.72%	-17.87%	-16.29%

Source: S&P Global Market Intelligence.